Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2022 08:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results

LEXINGTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
June 15, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022

LEXINGTON, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
June 10, 2022 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market

LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
May 20, 2022 09:17 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease

LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the...
May 05, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces First Quarter 2022 Financial Results

LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
May 05, 2022 16:02 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Receipt of Nasdaq Delisting Notice

LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
April 28, 2022 08:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Formation and Members of Scientific Advisory Board

LEXINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
April 27, 2022 08:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel

LEXINGTON, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
April 21, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Report First Quarter 2022 Financial Results on May 5, 2022

LEXINGTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
April 14, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Award

LEXINGTON, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...